Bharat Serums to assess sepsis drug Ulinastatin for Covid-19
The trial will involve Covid-19 patients who have mild to moderate symptoms of ARDS. Credit: Gerd Altmann from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more